B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3
Benzinga Newsdesk 11 months ago
NewsPrice TargetReiterationAnalyst Ratings
B. Riley Securities analyst William Woods reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and raises the price target from $2 to $3.
B. Riley Securities analyst William Woods reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and raises the price target from $2 to $3.